First results and experiences with our prematurity and dysmaturity prevention program (PDP-program).
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D002508:Cephalometry; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007752:Obstetric Labor, Premature / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D012146:Rest; D012306:Risk; D013223:Statistics as Topic
D000318:Adrenergic beta-Agonists; D005280:Fenoterol